USPTO serial 79366756
EVOKE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 20, 2026
- Examiner
- SMITH, TARYN E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EVOKE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patrick J. Gallagher
Patrick J. Gallagher Barnes & Thornburg LLP225 S. Sixth Street Suite 2800c/o Trademark DocketingMinneapolis, MN 55402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for programming and monitoring neuromodulation applications; data processing software for use in the field of healthcare, namely, downloadable and recorded computer software for processing data associated with neurostimulation; application software for use in the field of healthcare, namely, downloadable and recorded computer software for use in processing data associated with neuromodulation therapy; downloadable application software for cloud computing services for use in processing data associated with neuromodulation therapy; downloadable interface software for use in processing data associated with neuromodulation therapy; downloadable application software for managing the configuration and operation of implantable devices; downloadable mobile applications for processing data associated with neuromodulation therapy; downloadable computer software for database management; downloadable computer software using artificial intelligence for data analysis of neuromodulation; downloadable computer software using artificial intelligence software for analyzing healthcare data associated with neuromodulation therapy; downloadable computer programs for use in the field of healthcare using artificial intelligence for machine learning; computer hardware for use in the field of healthcare; data processing systems consisting of computer hardware for use in the field of healthcare; downloadable computer software for monitoring and programming neuromodulation parameters; downloadable computer software for use in measuring neurophysiological parameters associated with the neuromodulation therapy; wearable activity trackers; all of the foregoing concerning neurostimulation and neuromodulation of the spinal cord and peripheral nerves, and none of the foregoing concerning the collection of analyses of data and providing general report and summary related to brain and heart functions; none of the foregoing for or for use in connection with vehicles | ACTIVE | — |
| 010 | Medical apparatus, namely, neurological stimulators in the nature of nerve stimulator apparatus; medical apparatus for neurostimulation, namely, nerve stimulator apparatus; apparatus for analysing physiological parameters for medical purposes, namely, neuromodulation purposes; medical devices, namely, implantable pulse generators for neurostimulation and neuromodulation; electro- medical stimulation current apparatus for stimulating nerves; medical instruments for recording physiological data; electronic monitoring instruments for monitoring neurophysiological parameters associated with the neuromodulation therapy for medical use; impulse measuring apparatus for measuring nerve impulses for calibration of neurostimulators for medical use; microelectrical therapeutic apparatus for use in relieving neuropathic pain; testing probes for measuring nerve impulses for medical diagnostic purposes; apparatus for medical and therapeutic stimulation of the body, namely, medical devices in the nature of neurostimulators and neurostimulator accessories, namely, implantable pulse generators, neurostimulation leads, anchors in the nature of medical implants of artificial material to hold implantable devices in place, and trial stimulators being electronic nerve stimulators for medical purposes; pulse generators, namely, implantable pulse generators and external pulse generators for medical use, namely, for the management and treatment of conditions associated with the central and peripheral nervous system; neurostimulation leads that transmit electrical pulses to the spinal cord and record and transmit signals in response to electrical pulses for medical treatment purposes; electrical pain management apparatus, namely, electrical neurostimulators in the nature of electronic nerve stimulators for medical purposes; apparatus for medical and therapeutic stimulation of the body, namely, electrical neurostimulators in the nature of electronic nerve stimulators for medical purposes; apparatus for surgical purposes, namely, surgical instruments and apparatus; medical apparatus and instruments for medical analysis, diagnosing and treating chronic neuropathic pain, physiological conditions, and neurological conditions related to the central nervous system, and bladder disorders; apparatus for medical and therapeutic stimulation of the body, namely, electronic stimulation apparatus for nerves used to stimulate in order to diagnose, monitor and treat neuropathic pain, neurological conditions, movement disability, and physiological conditions; electrical pain management apparatus, namely, electrical stimulation apparatus for pain management; electro-medical stimulation current apparatus for stimulating neuromuscular tissue; electronic medical apparatus for physiological and neurological diagnosis, namely, electronic medical apparatus for diagnosing neurological disease; electronic medical apparatus for neurological monitoring; electronic medical apparatus for treating neuropathic pain, neurological conditions, physiological conditions, and movement disability for therapeutic use; electrical medical apparatus for nerve stimulation for physical therapy purposes; micro electrical therapeutic apparatus for use in relieving pain; scientific electrical apparatus for medical treatment purposes, namely, medical apparatus in the nature of electronic nerve stimulators for treating neuropathic pain, neurological conditions, physiological conditions, movement disability and for the management and treatment of conditions associated with the central and peripheral nervous systems; biofeedback sensors for measuring neuromuscular signals for medical use; apparatus for medical and therapeutic stimulation of the body, namely, medical apparatus in the nature of electrical stimulation apparatus for the management and treatment of conditions associated with the central and peripheral nervous systems; apparatus for medical diagnosis, namely, apparatus for the diagnosis of conditions associated with the central and peripheral nervous systems; apparatus for medical rehabilitation, namely, medical apparatus for the management and treatment of conditions associated with the central and peripheral nervous systems; diagnostic detection apparatus for medical use, namely, apparatus to detect pain levels in patients with injuries through the use of implanted sensors that measure the amount of stimulation traveling through nerve tissue; electro medical instruments, namely, medical instruments for the management and treatment of conditions associated with the central and peripheral nervous systems; electro-medical stimulation current apparatus, namely, medical apparatus for the management and treatment of conditions associated with the central and peripheral nervous systems; electronic apparatus for medical purposes, namely, medical apparatus in the nature of electronic nerve stimulators for the management and treatment of conditions associated with the central and peripheral nervous systems; electronic medical instruments, namely, medical instruments in the nature of electronic nerve stimulators for management and treatment of conditions associated with the central and peripheral nervous systems; medical apparatus and instruments, namely, medical apparatus for the management and treatment of conditions associated with the central and peripheral nervous systems; medical apparatus for nerve stimulation, namely, medical nerve stimulation apparatus for the management and treatment of conditions associated with the central and peripheral nervous systems; medical electronic therapeutic apparatus, namely, medical electronic therapeutic apparatus for the management of pain through the stimulation of nerves in spinal columns; medical testing apparatus, namely, medical diagnostic apparatus for detecting conditions associated with central and peripheral nervous systems for the management and treatment of these conditions; medical testing instruments, namely, medical diagnostic instruments for detecting conditions associated with central and peripheral nervous systems for the management and treatment of these conditions; medical therapy apparatus, namely, medical apparatus for the management and treatment of conditions associated with the central and peripheral nervous systems; medical therapy instruments, namely, medical instruments for the management and treatment of conditions associated with the central and peripheral nervous systems; scientific apparatus for medical diagnostic laboratory use, namely, apparatus for testing conditions associated with the central and peripheral nervous system for management and treatment of these conditions; scientific apparatus for use in medical diagnostic analytical tests, namely, apparatus for testing conditions associated with the central and peripheral nervous system for the management and treatment of these conditions; scientific electrical apparatus for medical diagnosis, namely, apparatus for the diagnosis of conditions associated with the central and peripheral nervous systems; scientific electrical apparatus for medical treatment purposes, namely, medical apparatus for the management and treatment of conditions associated with the central and peripheral nervous systems; sensor apparatus for medical use in generating signals in response to movements of the human body; sensors in the nature of a measurement apparatus for medical use, namely, sensors for measuring brain waves for the management and treatment of conditions associated with the central and peripheral nervous systems; testing probes for medical diagnostic purposes, namely, probes for the diagnosis of conditions associated with the central and peripheral nervous systems; microelectrical therapeutic apparatus for use in relieving pain, namely, microelectrical therapeutic medical apparatus for the management and treatment of conditions associated with the central and peripheral nervous systems; none of the foregoing being hearing aids or goods for use in the diagnosis, treatment or monitoring of hearing loss | ACTIVE | — |
| 042 | Scientific and technological services in the field of neuromodulation, namely, scientific research and development in the field of neuromodulation; scientific research services in the field of neuromodulation; scientific research relating to neuromodulation; scientific research and development services in the field of health care as it relates to neuromodulation; scientific research and development services in the field of health care as it relates to neurostimulation; information services, namely, providing scientific research information in the field of neuromodulation; providing scientific research information in the field of neurostimulation and neuromodulation; software development, namely, development and testing of computer methods, algorithms and software, all in the field of healthcare; software as a service (SaaS) services featuring software for monitoring, identifying, analyzing, and configuring neurophysiological parameters associated with the neuromodulation therapy for medical use; platform as a service (PaaS) featuring computer software platforms for diagnosing and administering neuromodulation therapy for pain related complications, movement disorders, neurophysiological disorders; data as a service services, namely providing on-line non-downloadable software for diagnosing and administering neuromodulation therapy for pain related complications, movement disorders, neurophysiological disorders; providing scientific and technological research information, namely, providing scientific research information and underlying data in relation to scientific and technological research and development; updating and maintenance of computer software, all in the field of healthcare; information technology services for the healthcare industries, namely, onsite and remote management of information technology (IT) systems, namely, installation, maintenance and repair of computer software; computer programming, namely, writing of computer programs for medical applications concerning neurostimulation and neuromodulation; computer programming, namely, compilation of computer programmes for research data in the field of neurostimulation and neuromodulation; information and advisory related to all of the aforesaid services; all of the foregoing concerning neurostimulation and neuromodulation of the spinal cord and peripheral nerves; none of the foregoing relating to software that allows users to access data, reports and summaries related to patients' brain and heart functions, and none of the foregoing concerns the field of pharmaceutical drugs; none of the foregoing for or in connection with vehicles | ACTIVE | — |
| 044 | Consulting services in the field of health; healthcare services; healthcare advisory services related to neuromodulation therapy; health screening services in the field of neuromodulation therapy for pain related complications, movement disorders, neurophysiological disorders; medical health assessment services; health care services, namely, neuromodulation therapy services; medical care in the nature of monitoring of patients for medical purposes; health care services, namely, medical care and analysis services relating to the treatment of patients in the field of neuromodulation; all of the foregoing concerning neurostimulation and neuromodulation of the spinal cord and peripheral nerves | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Saluda Medical Pty Ltd
- Other trademarks owned by Saluda Medical Pty Ltd
- Other trademarks owned by Saluda Medical Pty Ltd
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EVOKE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 13, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 23, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 23, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 20, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 20, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 20, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 11, 2025 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 2, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 2, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 26, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 26, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 25, 2025 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 5, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 5, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 5, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 5, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 29, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 29, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 29, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 30, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 4, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 4, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 15, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 15, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 12, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 16, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 16, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 1, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Feb 1, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 1, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 1, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 30, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 29, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 30, 2023 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Oct 28, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 10, 2023 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 23, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 11, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 7, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 6, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |